Upcoming event

ARANOTE study

2025-04-03


Our chief editor Dr. Giancarlo Marra talks to Prof. Fred Saad on the ARANOTE study: Darolutamide in combination with androgen-deprivation therapy in patients with metastatic hormone-sensitive prostate cancer (mHSPC).